|
|
| From Insights To Impact: Predictive Models And PAT For More Efficient And Robust Biologics Manufacturing | Bringing a biologic from cell culture to commercial vial requires precise, data-driven scale-up strategies that maintain product quality, process consistency, and supply reliability. Biological variability, engineering constraints, and critical quality attributes must remain balanced throughout development. Drug product formulation, particularly lyophilization, adds further complexity, influencing stability, shelf life, efficiency, and cost. This webinar explores predictive modeling and Process Analytical Technology enable deeper process understanding, real-time control, and informed decision-making across drug substance and product manufacturing. |
|
|
|
|
| How This CDMO Model Is Empowering Emerging Biotechs | Article | Cytovance Biologics | For emerging biotechs looking to refine their development processes and boost their chances of commercial success, exploring these partnership opportunities could prove invaluable. |
|
|
|
|
|
By Jeffrey S. Buguliskis, Ph.D., Deputy Chief Editor, Outsourced Pharma | From formulation and packaging to partner selection, early outsourcing decisions help determine whether a medicine can reach patients at a cost the market can sustain. | |
|
|
Setting Your MES Up For Long-Term Success | By Sri Harsha Chakrapani | Don't wait until manufacturing execution system (MES) configuration to answer these 7 questions. Define your manufacturing process before digitizing it. |
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
|
|
| What It Takes To Lead Quality With Helen Bickley | Q&A | FUJIFILM Biotechnologies | Quality is no longer just about compliance. See how a unified, data‑driven quality mindset supports scalable manufacturing, reduces variability, and helps organizations meet expectations. |
|
|
|
|
|
| Expanding Subcutaneous Design Brick By Brick | Article | BD Medical - Pharmaceutical Systems | Biologics are growing more complex. But what if the syringe itself could unlock new possibilities? Discover the technology “bricks” quietly reshaping subcutaneous drug delivery. |
|
|
|
|
|
|
| Join us on October 27 for Driving Biologics Manufacturing Innovation and Fill-Finish Excellence. Explore the technologies, capabilities, and strategies shaping both biologics and sterile drug product manufacturing. Leading CDMOs will discuss cell line development, fermentation, purification, sterile filling, lyophilization, packaging, and quality oversight, helping sponsors evaluate manufacturing partners, navigate scale-up and technology transfer, and prepare for successful clinical and commercial production. |
|
|
|
|
|
|
|
|
|
OUTSOURCED PHARMA CAPABILITIES UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capabilities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
| Connect With Outsourced Pharma: |
|
|
|
